Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of twin and autologous transplants for multiple myeloma.
Bashey A, Pérez WS, Zhang MJ, Anderson KC, Ballen K, Berenson JR, To LB, Fonseca R, Freytes CO, Gale RP, Gibson J, Giralt SA, Kyle RA, Lazarus HM, Maharaj D, McCarthy PL, Milone GA, Nimer S, Pavlovsky S, Reece DE, Schiller G, Vesole DH, Hari P; Plasma Cell Disorders Working Committee. Bashey A, et al. Among authors: reece de. Biol Blood Marrow Transplant. 2008 Oct;14(10):1118-1124. doi: 10.1016/j.bbmt.2008.07.007. Biol Blood Marrow Transplant. 2008. PMID: 18804041 Free PMC article. Clinical Trial.
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Reece DE, Barnett MJ, Shepherd JD, Hogge DE, Klasa RJ, Nantel SH, Sutherland HJ, Klingemann HG, Fairey RN, Voss NJ, et al. Reece DE, et al. Blood. 1995 Jul 15;86(2):451-6. Blood. 1995. PMID: 7541661 Free article. Clinical Trial.
Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
Koç ON, Gerson SL, Phillips GL, Cooper BW, Kutteh L, Van Zant G, Reece DE, Fox RM, Schupp JE, Tainer N, Lazarus HM. Koç ON, et al. Among authors: reece de. Bone Marrow Transplant. 1998 Feb;21(4):337-43. doi: 10.1038/sj.bmt.1701096. Bone Marrow Transplant. 1998. PMID: 9509966 Clinical Trial.
Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.
Bladé J, Samson D, Reece D, Apperley J, Björkstrand B, Gahrton G, Gertz M, Giralt S, Jagannath S, Vesole D. Bladé J, et al. Br J Haematol. 1998 Sep;102(5):1115-23. doi: 10.1046/j.1365-2141.1998.00930.x. Br J Haematol. 1998. PMID: 9753033 Free article. No abstract available.
New advances in multiple myeloma.
Reece DE. Reece DE. Curr Opin Hematol. 1998 Nov;5(6):460-4. doi: 10.1097/00062752-199811000-00018. Curr Opin Hematol. 1998. PMID: 9814656 Review.
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Lazarus HM, Rowlings PA, Zhang MJ, Vose JM, Armitage JO, Bierman PJ, Gajewski JL, Gale RP, Keating A, Klein JP, Miller CB, Phillips GL, Reece DE, Sobocinski KA, van Besien K, Horowitz MM. Lazarus HM, et al. Among authors: reece de. J Clin Oncol. 1999 Feb;17(2):534-45. doi: 10.1200/JCO.1999.17.2.534. J Clin Oncol. 1999. PMID: 10080597 Clinical Trial.
271 results